Angela Orcurto

Complementary medicine use during cancer treatment and potential herb-drug interactions from a cross-sectional study in an academic centre

Mégane Jermini, Julie Dubois, Pierre‐Yves Rodondi et al. · Scientific Reports · 2019 · 129 citations · Full text

Medicine, Oncology, Pharmacology +12

First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors

Elizabeth J. Davis, Juan Martín-Liberal, Rebecca Kristeleit et al. · Journal for ImmunoTherapy of Cancer · 2022 · 93 citations · Full text

Medicine, Oncology, Pharmacology +16

Response to tumor-infiltrating lymphocyte adoptive therapy is associated with preexisting CD8 ⁺ T-myeloid cell networks in melanoma

David Barras, Eleonora Ghisoni, Johanna Chiffelle et al. · Science Immunology · 2024 · 91 citations · Full text

Medicine, Immunology, Oncology +11

Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanoma

Johanna Chiffelle, David Barras, Rémy Pétremand et al. · Immunity · 2024 · 43 citations

Life Sciences, Immunology, Oncology +16

Long-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study

Theresa Medina, Jason Chesney, Harriet M. Kluger et al. · Journal of Clinical Oncology · 2025 · 32 citations

Life Sciences, Immunology, Oncology +17